SURAT, INDIA – Anupam Rasayan, a leading player in the Indian custom synthesis and specialty chemical industry, has announced the signing of a Letter of Intent (LoI) with a prominent Japanese specialty chemical company.

The agreement, which spans over five years, entails a revenue worth $265 Mn (approximately ₹2,186 crores) to supply a new age patented life science active ingredient.

The next eighteen months will be dedicated to the validation phase of the product. Upon successful validation, the supply of the new product will commence from CY2025. The active ingredient will be manufactured at Anupam Rasayan’s existing multipurpose manufacturing facilities.

This contract showcases Anupam Rasayan’s strong foothold in the specialty chemical market and its capacity to meet the growing global demand for new-age life science ingredients.

The successful validation and subsequent production of this active ingredient could further solidify Anupam Rasayan’s position as a trusted supplier of innovative chemical solutions in the global market. The news is anticipated to boost investor confidence and add impetus to the company’s future growth plans.

Anand Desai — Anupam Rasayan Managing Director said: “We are pleased to announce that we will be the primary global supplier of this new age patented life science active ingredient to one of the leading Japanese specialty chemical companies with the support of our Japanese business development team.

“With the addition of this new customer, we are delighted to include another renowned Japanese multinational in our customer portfolio. As we are fully backward integrated for this molecule, we can provide supply chain assurance to the customer without dependencies on supplies from other geographies.”

“The signing of this LOI represents a significant milestone for us, further cementing our position as a trusted provider of high-end customized molecules. We are excited about the opportunities this partnership brings.”

  Anand Desai, Anupam Rasayan, India, Japan